Regulatory agencies, including the FDA and EMA, are urging both patients and healthcare providers to remain alert. They emphasize the importance of reviewing medication safety updates and discussing any concerns with medical professionals before starting or continuing treatment.

One of the primary dangers linked to these medications is the formation of thrombi, or blood clots. Clotting is a natural process that prevents excessive bleeding after injury, but when it occurs abnormally inside a vein or artery, it can be life-threatening.

Blood clots can obstruct blood flow to essential organs, depriving them of oxygen and nutrients. Depending on where the blockage occurs, this can result in serious complications such as pulmonary embolism, deep vein thrombosis, strokes, or heart attacks.

Pulmonary embolism happens when a clot travels to the lungs, blocking blood supply. This can cause sudden shortness of breath, chest pain, and, in severe cases, death if not treated urgently.